Businesswire News Releases

Apr 25, 2024 07:00 ET
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Rese
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the treatment of retinitis pigmentosa....
Apr 25, 2024 07:00 ET
Comcast Reports 1st Quarter 2024 Results
Comcast Corporation (NASDAQ: CMCSA) today reported results for the quarter ended March 31, 2024....
Apr 25, 2024 07:00 ET
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three months ended March 31, 2024....
Apr 25, 2024 07:00 ET
Flygreen Recognized as a Top 10 Innovator at the 2024 Canadian Business Innovation Awards
Flygreen™, a Momentum Ventures subsidiary that offers customized private jet experiences with a commitment to sustainability and environmental responsibility, is proud to announce that it has been named as a top 10 innovator at the 2024 Canadian Business I...
Apr 25, 2024 07:00 ET
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET....
Apr 25, 2024 07:00 ET
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will hos...
Apr 25, 2024 07:00 ET
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations
Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce its financial and operating results for the fourth quarter and fiscal year ended December 31, 2023. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). For a more comprehensive overview of the corporate and financial highlights presented in this news release, please refer to Indiva's Management's Discus...
Apr 25, 2024 07:00 ET
Intevac Announces First Quarter 2024 Financial Results
Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the first quarter ended March 30, 2024....
Apr 25, 2024 07:00 ET
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Laser Photonics Corporation (LPC), a leading global developer of industrial laser systems for laser cleaning and other material processing applications, highlights a key application for its
Apr 25, 2024 07:00 ET
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
LiveWire Group, Inc. (“LiveWire” or the “Company”) (NYSE: LVWR) today reported first quarter 2024 results....
Apr 25, 2024 07:00 ET
Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it published an article in the Experimental and Therapeutic Medicine Journal, titled “Long-term complete response to namodenoson in liver cancer with Child-Pugh B cirrhosis: A case report” (
Apr 25, 2024 07:00 ET
MindMed to Present at Upcoming May Medical Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study of MM120 in Generalized Anxiety Disorder (GAD), as well as multiple presentations describing the epidemiology and growing burden of GAD at two upcoming medical conferences:...
Apr 25, 2024 07:00 ET
Mission Bio's New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies. Measuring predicted translocations along with on- and off-target editing at single-cell resolution can enable dev...
Apr 25, 2024 07:00 ET
Newmont Reports First Quarter 2024 Results
Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) (Newmont or the Company) today announced first quarter 2024 results and declared a first quarter dividend of $0.25 per share....
Apr 25, 2024 07:00 ET
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology
Science Corporation (“Science”), a leader in brain-computer interface (“BCI”) technology and the developer of the
Apr 25, 2024 07:00 ET
TelevisaUnivision Announces First Quarter 2024 Results
TelevisaUnivision, the world's leading Spanish-language media and content company, today announced financial results for the first quarter ended March 31, 2024. Please visit the company’s Investor Relations website at investors.televisaunivision.com to view the financial results and earnings mater...
Apr 25, 2024 07:00 ET
Ziff Davis to Participate in Two Investor Conferences in May
Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in two investor conferences in May....
Apr 25, 2024 06:59 ET
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Bristol Myers Squibb (NYSE: BMY) today reports results for the first quarter of 2024, which reflect meaningful progress in the company's growth portfolio and pipeline....
Apr 25, 2024 06:55 ET
Canada Goose to Announce Fourth Quarter and Fiscal Year 2024 Financial Results May 16, 2024
Canada Goose Holdings Inc. (NYSE, TSX: GOOS) plans to announce results for the fourth quarter and fiscal year 2024, which ended March 31, 2024, before markets open on Thursday, May 16, 2024....
Apr 25, 2024 06:55 ET
First Foundation Inc. Reports First Quarter 2024 Financial Results
First Foundation Inc. (NYSE: FFWM), a financial services company with two wholly-owned operating subsidiaries, First Foundation Advisors (“FFA”) and First Foundation Bank (“FFB”), today reported its financial results for the quarter ended March 31, 2024....